Cell Biology and Gene Expression Section, Laboratory of Neurogenetics, National Institute of Aging, National Institutes of Health, Bethesda, MD, USA.
Department of Pharmacology, UCL School of Pharmacy, University College London, London, UK.
Hum Mol Genet. 2018 Sep 15;27(18):3257-3271. doi: 10.1093/hmg/ddy232.
Mutations in leucine-rich repeat kinase 2 (LRRK2) segregate with familial Parkinson's disease (PD) and genetic variation around LRRK2 contributes to risk of sporadic disease. Although knockout (KO) of Lrrk2 or knock-in of pathogenic mutations into the mouse germline does not result in a PD phenotype, several defects have been reported in the kidneys of Lrrk2 KO mice. To understand LRRK2 function in vivo, we used an unbiased approach to determine which protein pathways are affected in LRRK2 KO kidneys. We nominated changes in cytoskeletal-associated proteins, lysosomal proteases, proteins involved in vesicular trafficking and in control of protein translation. Changes were not seen in mice expressing the pathogenic G2019S LRRK2 mutation. Using cultured epithelial kidney cells, we replicated the accumulation of lysosomal proteases and demonstrated changes in subcellular distribution of the cation-independent mannose-6-phosphate receptor. These results show that loss of LRRK2 leads to co-ordinated responses in protein translation and trafficking and argue against a dominant negative role for the G2019S mutation.
富含亮氨酸重复激酶 2(LRRK2)中的突变与家族性帕金森病(PD)分离,LRRK2 周围的遗传变异导致散发性疾病的风险增加。尽管 Lrrk2 的敲除(KO)或致病突变的敲入到小鼠种系中不会导致 PD 表型,但在 Lrrk2 KO 小鼠的肾脏中已经报道了几种缺陷。为了了解 LRRK2 在体内的功能,我们使用了一种无偏的方法来确定 LRRK2 KO 肾脏中受影响的蛋白途径。我们提名了细胞骨架相关蛋白、溶酶体蛋白酶、参与囊泡运输和蛋白质翻译控制的蛋白的变化。在表达致病性 G2019S LRRK2 突变的小鼠中没有观察到变化。使用培养的上皮肾细胞,我们复制了溶酶体蛋白酶的积累,并证明了阳离子非依赖性甘露糖-6-磷酸受体的亚细胞分布发生了变化。这些结果表明 LRRK2 的缺失导致蛋白质翻译和运输的协调反应,并排除了 G2019S 突变的显性负作用。